 Focused on developing life-changing therapies for patients with cancer and diabetes Advancing lead product REQORSA immunogene therapy for non-small cell lung cancer Struck licensing agreement with the University of Pittsburgh for diabetes gene therapy What Genprex does: Genprex Inc NASDAQ:GNPX is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The Austin, Texas companys technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations who currently have limited treatment options. 